Inflammatory signaling promotes anoikis resistance in cancer cells primarily by activating survival pathways like NF-κB, which up-regulates anti-apoptotic proteins and cytokines such as IL-6 and TNF-α. The gene discussed is NFKB1; the disease is cancer.